Also listed on Corvidia Therapeutics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Feb 1, 2038 · High confidence
20-year base term ends Feb 1, 2038
Held by Novo Nordisk A/S
Filed Jul 30, 2019 as application 16/482,038 · Granted Dec 21, 2021
Base term, 20 years from filing
Today
2018
2038
Clock starts
Feb 1, 2018
Feb 1, 2018
Term ends
Feb 1, 2038
Feb 1, 2038
Granted
Dec 21, 2021
Dec 21, 2021
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 1, 2018, when application PCT/US2018/016508, the earliest non-provisional in its chain, was filed (this one was filed Jul 30, 2019) | Feb 1, 2038 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 1, 2038 | High confidence |
This family
| Application PCT/US2018/016508 | PCT application no patent term | no patent term |
| US 11,203,636 | this patent Feb 2038 | Feb 2038 |
| US 12,600,773 | In force no later than Mar 2040 | no later than Mar 2040 |
| Application 19/398,713 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 1, 2019 Reel 50591, frame 80 | Testani, Jeffrey Moore; Rao, Veena | Yale University | Assignment of Assignor's Interest |
| Oct 24, 2019 Reel 50813, frame 835 | Kakkar, Rahul; Devalaraja, Madhav N.; Lo, Chih-hung | Corvidia Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jan 20, 2021 Reel 54965, frame 550 | Corvidia Therapeutics, Inc. | Novo Nordisk A/S | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2038
Term ends Feb 1, 2038. Maintenance fees still fall due before then
Citations
2
later US patents cite this one
That is above the median of utility patents granted in 2021 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.